My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Premier, Inc. - Class A Common Stock (NQ:PINC)

27.81 +0.02 (+0.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Premier, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Premier, Inc. to Report Fiscal 2025 Second-Quarter Results and Host Conference Call on February 4, 2025
From Premier, Inc.
Via Business Wire
Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 14, 2025
From Premier, Inc.
Via Business Wire
Premier, Inc. Appoints David Zito as President, Performance Services
From Premier, Inc.
Via Business Wire
Unveiling 5 Analyst Insights On Premier
 
Via Benzinga
Assessing Premier: Insights From 4 Financial Analysts
 
Via Benzinga
NASDAQ:PINC: good value for what you're paying.
PREMIER INC-CLASS A (NASDAQ:PINC) is probably undervalued for the fundamentals it is displaying. 
Via Chartmill
Premier, Inc. Reports Fiscal-Year 2025 First-Quarter Results
From Premier, Inc.
Via Business Wire
Premier, Inc. Declares Quarterly Cash Dividend
From Premier, Inc.
Via Business Wire
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
 
Via Benzinga
Premier, Inc. to Report Fiscal 2025 First-Quarter Results and Host Conference Call on November 5, 2024
From Premier, Inc.
Via Business Wire
Decoding 4 Analyst Evaluations For Premier
 
Via Benzinga
Unveiling 4 Analyst Insights On Premier
 
Via Benzinga
Premier, Inc. Divests Ownership Position in S2S Global Through New Partnership With Prestige Ameritech
From Premier, Inc.
Via Business Wire
PINC Stock Earnings: Premier Beats EPS, Beats Revenue for Q4 2024
PINC stock results show that Premier beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Premier, Inc. Appoints Glenn Coleman as Chief Administrative and Financial Officer
From Premier, Inc.
Via Business Wire
Premier, Inc. Reports Fiscal-Year 2024 Fourth-Quarter and Full-Year Results
From Premier, Inc.
Via Business Wire
AllSpire Health Partners Selects Premier, Inc. as its National GPO
From Premier, Inc.
Via Business Wire
Premier, Inc. Declares Quarterly Cash Dividend
From Premier, Inc.
Via Business Wire
Premier, Inc. to Report Fiscal 2024 Fourth-Quarter and Full-Year Results and Host Conference Call on August 20, 2024
From Premier, Inc.
Via Business Wire
Premier’s PINC AI™ and Fortune Name the Nation’s 15 Top Health Systems™
From Premier, Inc.
Via Business Wire
Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 14, 2024
From Premier, Inc.
Via Business Wire
Premier, Inc. Announces Cross-Industry Initiative to Improve Diagnosis and Care for Chronic Kidney Disease
From Premier, Inc.
Via Business Wire
PINC Stock Earnings: Premier Beats EPS, Beats Revenue for Q3 2024
PINC stock results show that Premier beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results
From Premier, Inc.
Via Business Wire
Premier, Inc. Declares Quarterly Cash Dividend
From Premier, Inc.
Via Business Wire
Premier’s PINC AI™ and Fortune Name the Nation’s 100 Top Hospitals®
From Premier, Inc.
Via Business Wire
Premier, Inc. to Report Fiscal 2024 Third-Quarter Results and Host Conference Call on May 7, 2024
From Premier, Inc.
Via Business Wire
Premier, Inc. to Participate in Barclays Global Healthcare Conference on March 12, 2024
From Premier, Inc.
Via Business Wire
PINC AI™ and Fortune Name the Nation’s 50 Top Cardiovascular Hospitals™
From Premier, Inc.
Via Business Wire
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.